flufenoximacil
Commercial- Indications
- Non-selective herbicide
Company intelligence / Profile preview
KingAgroot
Qingdao, Shandong, China
- Ownership
- Private
- Development stage
- Commercial
01
Overview
KingAgroot has achieved commercial success with its novel non-selective herbicide Flufenoximacil ("FFO"), which received Chinese regulatory approval in early 2024. The company’s proprietary KSE gene editing platform enables the creation of new crop varieties with enhanced agronomic traits. Field trials and international partnerships are ongoing to expand product reach globally. The company’s innovations address both chemical weed management and genetic improvement of staple food crops to support world food security goals.
- Therapeutic areas
- Other
- Modalities
- Small moleculeGene editing technologyBiotech breeding/crop trait engineering
- Industry
- Agriculture & AgTech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Nufarm Australia—partnership to develop/register Flufenoximacil for Australian market as a stand-alone knockdown broad-spectrum herbicide
Beyond the preview
Go deeper on KingAgroot.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KingAgroot.